Cancer is one of the most common cause of death and one of the most severe diagnoses patients can receive in modern medicine. Its treatment normally involves a combination of chemotherapy, tumor resection and radiation therapy, often accompanied by severe side effects causing high psychological strain. In recent years treatment shifts from general approaches to individual therapy regiments for individual patients. A similar situation can be assumed for neurodegenerative diseases like Alzheimer’s or Parkinson’s disease, for which oxidative stress is a common contributing factor. For both cancer and neurodegenerative diseases the development of new pharmacological compounds and treatment strategies is a high priority goal facilitating the ne...